@article{a64587dc764d474998b0f4460c9b5e53,
title = "Clinical and laboratory factors associated with shear-dependent platelet hyper-reactivity in patients on chronic aspirin therapy",
keywords = "Coronary artery disease, PFA-100, Platelet hyper-reactivity, VonWillebrand factor",
author = "Nazarian, {Susanna M.} and Thompson, {Jason B.} and Gluckman, {Tyler J.} and Katherine Laws and Jani, {Jayesh T.} and Kickler, {Thomas S.} and Rade, {Jeffrey J.}",
note = "Funding Information: This work was supported by the Johns Hopkins General Clinical Research Center (funded by National Institutes of Health M01RR00005), funding from the National Institutes of Health 1KL2RR025006-01 (SMN) and a grant from the Medicines Company, Parsippany, NJ (JJR). PFA-100 CADP and CEPI agonist cartridges were provide by Siemens Healthcare Diagnostics Inc., Glascow, DE. The principal and co-investigators were solely responsible for the design of this and the parent RIGOR study, the collection, management and analysis of the data, as well as writing of the manuscript. None has any reportable conflicts of interest.",
year = "2010",
month = nov,
doi = "10.1016/j.thromres.2009.04.016",
language = "English (US)",
volume = "126",
pages = "379--383",
journal = "Thrombosis research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "5",
}